Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
  Home Print this page Email this page Small font sizeDefault font sizeIncrease font size Users Online: 377  

  Article Access Statistics

Year : 2017 | Volume:  16 | Issue Number:  2 | Page:  126-132

ORIGINAL ARTICLE

Peptide receptor radionuclide therapy with 177Lu-DOTATATE for metastatic neuroendocrine tumor occurring in association with multiple endocrine neoplasia type 1 and cushing's syndrome
Naik Chinna, Basu Sandip

Number of times this article was viewed 2817
Number of times this article has been printed  from the site 84
Number of times this article was emailed to others 0
Remarks given by readers [ Read ] 0

 
  Feedback 
  Subscribe 
 Back To Article

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal
Sitemap | What's New Feedback | Copyright and Disclaimer | Privacy Notice
© World Journal of Nuclear Medicine | Published by Wolters Kluwer - Medknow
New site Online since 10 March, 2011